Inhalable insulin - Wikipedia
Exubera, developed by Inhale Therapeutics (later named Nektar Therapeutics), became the first inhaled insulin product to be marketed, in 2006 by Pfizer, [3] but poor sales led Pfizer to withdraw it in 2007. [4] .
Inhaled insulin: Exubera - PubMed
Exubera is an effective inhaled insulin for preprandial use in type 1 or 2 diabetes. Improved patient satisfaction over injected insulin increases its potential for use earlier in the treatment of type 2 diabetes.
Insulin Inhalation Powder (Exubera) for Diabetes Mellitus | AAFP
2007年5月15日 · Insulin inhalation powder (Exubera), also called inhaled insulin, is a dry powder form of rapid-acting insulin delivered by oral inhalation.
Inhaled human insulin (Exubera®): clinical profile and patient ...
2022年12月28日 · Inhaled human insulin (Exubera®) is a rapid-acting regular human insulin administered by oral inhalation before meals. It provides a non-invasive alternative to multiple subcutaneous injections for the treatment of hyperglycemia in adult …
EXUBERA®(insulin human [rDNA origin]) Inhalation ... - DailyMed
EXUBERA delivers insulin by oral inhalation. The insulin is absorbed as quickly as subcutaneously administered rapid-acting insulin analogs and more quickly than subcutaneously administered regular human insulin in healthy subjects and in patients with type 1 or type 2 diabetes (see Figure 1).
Exubera inhaled insulin: a review - PubMed
The focus of this review is inhaled insulin, specifically Exubera, which represents a novel prandial insulin delivery method. Fear of hypoglycaemia and the reluctance of patients to use multiple daily injection regimens is a major barrier to achieving good glycaemic control in patients with type 1 and type 2 diabetes.
EXUBERA- insulin human EXUBERA- insulin human aerosol ... - DailyMed
EXUBERA is a prescription medicine that contains an insulin powder that you breathe in (inhale) through your mouth using the EXUBERA ® Inhaler. It is used to treat adults with diabetes. It helps to control high blood sugar. For adults with type 2 diabetes, EXUBERA may be used by itself, or with diabetes pills, or with a longer-acting insulin.
Inhaled Insulin: Exubera - Semantic Scholar
2005年5月1日 · Improved patient satisfaction over injected insulin increases its potential for use earlier in the treatment of type 2 diabetes, and Exubera is an effective inhaled insulin for preprandial use in type 1 or 2 diabetes.
Exubera(®) (inhaled insulin): an evidence-based review of its ...
Aims: This review assesses the evidence for the therapeutic value of inhaled insulin (Exubera (®)) in the management of type 1 and type 2 diabetes. Evidence review: Evidence indicates that glycemic control, as measured by plasma HbA (1c) levels, with Exubera is as effective as subcutaneous insulin in patients with type 1 or type 2 diabetes.
Exubera(®) (inhaled insulin): an evidence-based review of its ...
2005年6月30日 · Evidence indicates that glycemic control, as measured by plasma HbA (1c) levels, with Exubera is as effective as subcutaneous insulin in patients with type 1 or type 2 …
- 某些结果已被删除